OSR Health, Inc. has made a significant announcement regarding its financial oversight. The company disclosed that its independent auditor, Shinhan Accounting Corporation, has resigned effective immediately. This decision, which came on November 6, 2026, raises concerns about the company's financial governance and could influence investor confidence.

Shinhan Accounting Corporation, a member of RSM International, cited overdue fees for its audit of OSR Health's 2025 financial statements as a reason for its resignation. The firm indicated that these overdue fees may create a self-interest threat to its independence. Following this, the Audit Committee of OSR Health's Board of Directors accepted the resignation and has begun the process of engaging a successor firm.

Background

OSR Health, Inc. operates in the surgical and medical instruments and apparatus industry, classified under SIC code 3841. The company trades on the OTC market under the ticker symbols OSRH and OSRHW. It is incorporated in Delaware and has its principal offices located in Bellevue, Washington.

In recent filings, OSR Health has been active in disclosing various financial updates, including a 10-Q filing also made on November 13, 2026, which may provide further insights into its financial health and operational status.

What the Filing Says

The filing states, "On November 6, 2026, Shinhan Accounting Corporation... resigned as the independent registered public accounting firm engaged to audit the consolidated financial statements of OSR Health, Inc., effective immediately." The filing also notes that Shinhan's report for the fiscal years ended December 31, 2025, and 2024 did not contain any adverse opinions or disclaimers, except for an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.

Furthermore, it was noted that there were no disagreements with Shinhan that would require disclosure under Item 304(a)(1)(iv) of Regulation S-K, aside from previously disclosed material weaknesses in internal control over financial reporting.

Impact

This resignation may affect various stakeholders, including investors, employees, and regulatory bodies. Investors may view this as a red flag, potentially impacting their confidence in the company's financial reporting and governance. Employees may also feel the effects of any subsequent changes in management or operational strategies as the company seeks to establish a new auditing relationship.

What's Next

The company has not specified the timeline for appointing a new auditor. However, it is clear that the Audit Committee is actively engaged in the process of selecting a successor firm to ensure continued compliance with financial reporting standards. Further updates are expected in subsequent filings as the situation develops.

For more information, the full filing can be accessed under accession number 0001840425-26-000010.